FLT3 and acute myeloid leukemia: When we focused on the impact of FLT3/ITD AR on the clinical outcome in pediatric AML, especially in the subgroup of chemotherapy-only patients, high FLT3/ITD AR was apparently associated with poorer EFS and OS when compared with low AR.